These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2838352)

  • 1. Changes in low-Km cAMP phosphodiesterase activity in liver Golgi fractions from hyper- and hypoinsulinemic rats.
    Benelli C; Lopez S; Desbuquois B; Achagiotis C
    Diabetes; 1988 Jun; 37(6):717-22. PubMed ID: 2838352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute in vivo stimulation of low-Km cyclic AMP phosphodiesterase activity by insulin in rat-liver Golgi fractions.
    Benelli C; Desbuquois B; De Gallé B
    Eur J Biochem; 1986 Apr; 156(1):211-20. PubMed ID: 3007144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction.
    Geoffroy V; Fouque F; Lugnier C; Desbuquois B; Benelli C
    Arch Biochem Biophys; 2001 Mar; 387(1):154-62. PubMed ID: 11368177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction.
    Geoffroy V; Fouque F; Nivet V; Clot JP; Lugnier C; Desbuquois B; Benelli C
    Eur J Biochem; 1999 Feb; 259(3):892-900. PubMed ID: 10092879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
    Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
    Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-dependent changes in subcellular distribution of liver insulin receptors in obese Zucker rats.
    López S; Desbuquois B; Postel-Vinay MC; Benelli C; Lavau M
    Diabetologia; 1988 Dec; 31(12):922-7. PubMed ID: 3071488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of the activity of 3', 5'-cyclic AMP phosphodiesterase by pancreatic hormones].
    Zin'ko NV; Starosel'tseva LK
    Probl Endokrinol (Mosk); 1979; 25(3):65-9. PubMed ID: 223145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP phosphodiesterase in diabetes. Effect of glyburide.
    Solomon SS; Deaton J; Shankar TP; Palazzolo M
    Diabetes; 1986 Nov; 35(11):1233-6. PubMed ID: 3019808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments.
    Weiss RM; Wheeler MA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):630-4. PubMed ID: 2846825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the subcellular distribution of insulin receptors in rat liver induced by acute endogenous hyperinsulinemia.
    Lopez S; Desbuquois B
    Endocrinology; 1983 Aug; 113(2):783-9. PubMed ID: 6347664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation.
    Degerman E; Smith CJ; Tornqvist H; Vasta V; Belfrage P; Manganiello VC
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):533-7. PubMed ID: 2153956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by thyroid status of hepatic low Km phosphodiesterase.
    Morgan DW; Shaheen O; Keyes WG; Heimberg M
    Endocrinology; 1982 Jan; 110(1):260-4. PubMed ID: 6274622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-related changes in the subcellular distribution of insulin receptors in intact rat liver: effects of acute hypoinsulinemia induced by diazoxide, somatostatin, and xylazine.
    López S; Desbuquois B
    Endocrinology; 1987 May; 120(5):1695-702. PubMed ID: 2882996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human placental cytosolic adenosine 3',5'-monophosphate phosphodiesterase by inhibitors and insulin treatment.
    Xiong LM; LeBon TR; Fujita-Yamaguchi Y
    Endocrinology; 1990 Apr; 126(4):2102-9. PubMed ID: 2156681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes of cyclic AMP phosphodiesterase activity in rat brain regions and a new phosphodiesterase inhibitor--nootropic agent adafenoxate.
    Stancheva SL; Alova LG
    Gen Pharmacol; 1991; 22(5):955-8. PubMed ID: 1662175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calmodulin-dependent cyclic AMP phosphodiesterase in liver plasma membranes: stimulated by insulin.
    Smoake JA; Moy GM; Fang B; Solomon SS
    Arch Biochem Biophys; 1995 Nov; 323(2):223-32. PubMed ID: 7487081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME; Garrett RL; Thompson WJ; Strada SJ
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide PDE-3. Quantitation of PDE-3A and -3B mRNAs in rat tissues by RNase protection assay.
    Nagaoka T; Shirakawa T; Kasuya J; Balon TW; Manganiello VC; Fujita-Yamaguchi Y
    Cell Biochem Biophys; 1998; 29(1-2):49-66. PubMed ID: 9631238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free stimulation of the insulin-sensitive cAMP phosphodiesterase by the joint actions of ATP and the soluble fraction from insulin-treated rat liver.
    Shibata H; Kono T
    Biochem Biophys Res Commun; 1990 Jul; 170(2):533-9. PubMed ID: 2166498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of cyclic nucleotide phosphodiesterases in liver endoplasmic reticulum.
    Cercek B; Wilson SR; Houslay MD
    Biochem J; 1983 Jul; 213(1):89-97. PubMed ID: 6311161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.